These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21360486)

  • 1. Personalized medicine in rheumatoid arthritis: miles to go before we sleep.
    Plenge RM; Bridges SL
    Arthritis Rheum; 2011 Mar; 63(3):590-3. PubMed ID: 21360486
    [No Abstract]   [Full Text] [Related]  

  • 2. Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci.
    Plant D; Bowes J; Potter C; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; ; ; Barton A
    Arthritis Rheum; 2011 Mar; 63(3):645-53. PubMed ID: 21061259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics: Anti-TNF therapy in RA--towards personalized medicine?
    Verweij CL
    Nat Rev Rheumatol; 2011 Mar; 7(3):136-8. PubMed ID: 21304506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF antagonists opened the way to personalized medicine in rheumatoid arthritis.
    Breedveld F
    Mol Med; 2014 Dec; 20 Suppl 1(Suppl 1):S7-9. PubMed ID: 25549234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A personalized medicine approach to biologic treatment of rheumatoid arthritis: a preliminary treatment algorithm.
    Tak PP
    Rheumatology (Oxford); 2012 Apr; 51(4):600-9. PubMed ID: 21890615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis.
    Umiċeviċ Mirkov M; Cui J; Vermeulen SH; Stahl EA; Toonen EJ; Makkinje RR; Lee AT; Huizinga TW; Allaart R; Barton A; Mariette X; Miceli CR; Criswell LA; Tak PP; de Vries N; Saevarsdottir S; Padyukov L; Bridges SL; van Schaardenburg DJ; Jansen TL; Dutmer EA; van de Laar MA; Barrera P; Radstake TR; van Riel PL; Scheffer H; Franke B; Brunner HG; Plenge RM; Gregersen PK; Guchelaar HJ; Coenen MJ
    Ann Rheum Dis; 2013 Aug; 72(8):1375-81. PubMed ID: 23233654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and clinical markers for predicting treatment responsiveness in rheumatoid arthritis.
    Wu X; Sheng X; Sheng R; Lu H; Xu H
    Front Med; 2019 Aug; 13(4):411-419. PubMed ID: 30635780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical perspective of rheumatoid arthritis.
    Scherer HU; Burmester GR
    Eur J Immunol; 2009 Aug; 39(8):2044-8. PubMed ID: 19672900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GWAS replication study confirms the association of PDE3A-SLCO1C1 with anti-TNF therapy response in rheumatoid arthritis.
    Acosta-Colman I; Palau N; Tornero J; Fernández-Nebro A; Blanco F; González-Alvaro I; Cañete JD; Maymó J; Ballina J; Fernández-Gutiérrez B; Olivé A; Corominas H; Erra A; Canela-Xandri O; Alonso A; López Lasanta M; Tortosa R; Julià A; Marsal S
    Pharmacogenomics; 2013 May; 14(7):727-34. PubMed ID: 23651021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors.
    Bodio C; Grossi C; Pregnolato F; Favalli EG; Biggioggero M; Marchesoni A; Murgo A; Filippini M; Migliorini P; Caporali R; Pellerito R; Ciccia F; Sarzi-Puttini P; Perosa F; Paolazzi G; Hollan I; Bendtzen K; Meroni PL; Borghi MO
    Autoimmun Rev; 2020 May; 19(5):102509. PubMed ID: 32173513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel approaches to discovery of biomarkers in rheumatoid arthritis: comment on the article by Oswald et al.
    Hudson M; Baron M; Colmegna I; Bernatsky S; Klein Oros K; Pastinen T; Greenwood C
    Arthritis Rheumatol; 2015 May; 67(8):2276-7. PubMed ID: 25988805
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept.
    Ferreiro-Iglesias A; Montes A; Perez-Pampin E; Cañete JD; Raya E; Magro-Checa C; Vasilopoulos Y; Caliz R; Ferrer MA; Joven B; Carreira P; Balsa A; Pascual-Salcedo D; Blanco FJ; Moreno-Ramos MJ; Manrique-Arija S; Ordoñez MDC; Alegre-Sancho JJ; Narvaez J; Navarro-Sarabia F; Moreira V; Valor L; Garcia-Portales R; Marquez A; Gomez-Reino JJ; Martin J; Gonzalez A
    PLoS One; 2019; 14(2):e0213073. PubMed ID: 30818333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genome-wide association study identifies a new locus associated with the response to anti-TNF therapy in rheumatoid arthritis.
    Julià A; Fernandez-Nebro A; Blanco F; Ortiz A; Cañete JD; Maymó J; Alperi-López M; Fernández-Gutierrez B; Olivè A; Corominas H; Erra A; Acosta-Colman I; Alonso A; López-Lasanta M; Tortosa R; Tornero J; Marsal S
    Pharmacogenomics J; 2016 Apr; 16(2):147-50. PubMed ID: 25896534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply: To PMID 25371395.
    Gregersen PK; Oswald M; Curran M; Carulli J;
    Arthritis Rheumatol; 2015 May; 67(8):2277. PubMed ID: 25989099
    [No Abstract]   [Full Text] [Related]  

  • 15. Robin goodfellow.
    Rheumatology (Oxford); 2001 Jul; 40(7):838. PubMed ID: 11477300
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathway analysis to identify genetic variants associated with efficacy of adalimumab in rheumatoid arthritis.
    Eektimmerman F; Swen JJ; Böhringer S; Huizinga TW; Kooloos WM; Allaart CF; Guchelaar HJ
    Pharmacogenomics; 2017 Jul; 18(10):945-953. PubMed ID: 28639493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized medicine: predicting responses to therapy in patients with RA.
    van den Broek M; Visser K; Allaart CF; Huizinga TW
    Curr Opin Pharmacol; 2013 Jun; 13(3):463-9. PubMed ID: 23578763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of heritability of different outcomes for genetic studies of TNFi response in patients with rheumatoid arthritis.
    Umićević Mirkov M; Janss L; Vermeulen SH; van de Laar MA; van Riel PL; Guchelaar HJ; Brunner HG; Albers CA; Coenen MJ
    Ann Rheum Dis; 2015 Dec; 74(12):2183-7. PubMed ID: 25114059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis.
    Aterido A; Cañete JD; Tornero J; Blanco F; Fernández-Gutierrez B; Pérez C; Alperi-López M; Olivè A; Corominas H; Martínez-Taboada V; González I; Fernández-Nebro A; Erra A; López-Lasanta M; López Corbeto M; Palau N; Marsal S; Julià A
    Front Immunol; 2019; 10():1459. PubMed ID: 31312201
    [No Abstract]   [Full Text] [Related]  

  • 20. Killer immunoglobulin-like receptor and human leukocyte antigen-C genotypes in rheumatoid arthritis primary responders and non-responders to anti-TNF-α therapy.
    McGeough CM; Berrar D; Wright G; Mathews C; Gilmore P; Cunningham RT; Bjourson AJ
    Rheumatol Int; 2012 Jun; 32(6):1647-53. PubMed ID: 21373785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.